RxNorm Semantic Concepts Index - 264
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "264".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 26400 | Trichomycin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26400 | Trichomycin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26400 | Trichomycin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26402 | Cytidine monophosphate (CMP)-N-acetylneuraminate-lactosylceramide alpha-2,3-sialyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26402 | Cytidine monophosphate (CMP)-N-acetylneuraminate-lactosylceramide alpha-2,3-sialyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26402 | Cytidine monophosphate (CMP)-N-acetylneuraminate-lactosylceramide alpha-2,3-sialyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26402 | Cytidine monophosphate (CMP)-N-acetylneuraminate-lactosylceramide alpha-2,3-sialyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26412 | halazepam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 26412 | halazepam | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26412 | halazepam | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26412 | halazepam | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26412 | halazepam | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26413 | Haloacetate dehalogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26413 | Haloacetate dehalogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26416 | halometasone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 26416 | halometasone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26416 | halometasone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26416 | halometasone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26416 | halometasone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26420 | haloperidol decanoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 26420 | haloperidol decanoate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 26420 | haloperidol decanoate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 26422 | haloprogin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 26422 | haloprogin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26422 | haloprogin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26422 | haloprogin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26422 | haloprogin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26426 | Haloxon | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26426 | Haloxon | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26428 | Chlorhydroxyquinoline | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26428 | Chlorhydroxyquinoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26428 | Chlorhydroxyquinoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26428 | Chlorhydroxyquinoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26428 | Chlorhydroxyquinoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2644 | Cobalt radioisotope | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2644 | Cobalt radioisotope | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2644 | Cobalt radioisotope | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2644 | Cobalt radioisotope | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26444 | Hatching enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26444 | Hatching enzyme | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26444 | Hatching enzyme | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26460 | HDL - High density lipoprotein triglyceride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26460 | HDL - High density lipoprotein triglyceride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26460 | HDL - High density lipoprotein triglyceride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26492 | Hellebrin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26492 | Hellebrin | Full form of descriptor (FN) | NO |